All articles tagged: Malignant neoplasm of rectosigmoid junction (C19)

For patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for 10 of 13 obesity-associated cancers (OACs) compared with insulin, according to a study published online July 5 in JAMA Network Open.Lindsey Wang, from Case Western Reserve University School of Medicine

The potential approval of the first blood test for colorectal cancer this year could mark a significant breakthrough in cancer detection, potentially increasing the number of diagnoses for the second-highest cause of cancer death in the United States. While experts emphasize that the test would not replace colonoscopies, it could offer a less invasive alternative and encourage more people to under

ANU researchers discovered that Ku70, an immune protein, can be activated to inhibit bowel cancer by detecting damaged DNA in cells, potentially improving screening and treatment.

For patients with immunotherapy recalcitrant KRAS-mutated tumors, the cancer vaccine ELI-002 2P is safe and induces T-cell responses, according to a study published online Jan. 9 in Nature Medicine.Noting that the cancer vaccine ELI-002 2P enhances lymph node delivery and immune response using Amphiphile (Amph)-modification of G12D and

Robotic surgery for colorectal cancer (CRC) offers an advantage over conventional laparoscopy by improving textbook outcomes for right colectomy (RC) and left colectomy (LC), according to a study recently published in the World Journal of Surgical Oncology.Emile Farah, M.D., from the University of Texas Southwestern (UTSW) Medica

Adding a cup of beans to the usual diet enhances the gut microbiome and regulates host markers associated with metabolic obesity and colorectal cancer, according to a study published in the December issue of eBioMedicine.Xiaotao Zhang, M.D., Ph.D., from The University of Texas MD Anderson Cancer Center in Houston, and colleagues conduc

Most patients with microsatellite instability-high (MSI-H) colorectal cancer do not have recurrence after cessation of immunotherapy treatment, according to a study published in the December issue of Cancer Research Communications.Kristen Simmons, M.D., from the Baylor College of Medicine in Houston, and colleagues reviewed records fr

The NBC News article discusses the increasing cases of colon cancer in young adults and features personal stories of individuals who faced diagnostic challenges due to their age. It underscores the need for early detection and awareness of colon cancer symptoms in younger populations.

Personalized colorectal cancer (CRC) screening based on individual life expectancy may increase the value of CRC screening programs, according to a study published online Oct. 27 in the American Journal of Gastroenterology.Po-Hong Liu, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues examin

From 2004 to 2019, the risk for recurrence of colorectal cancer (CRC) decreased in patients with stages I to III disease, according to a study published online Nov. 16 in JAMA Oncology to coincide with the annual meeting of the Danish Surgical Society, held from Nov. 16 to 17 in Copenhagen.Jesper Nors, M.D., from Aarhus University Hosp

More than 10 percent of fecal immunochemical tests (FIT) for colorectal cancer cannot be processed by a laboratory, and fewer than half complete a subsequent FIT within 15 months, according to a study published online Nov. 3 in Cancer Epidemiology, Biomarkers & Prevention.Po-Hong Liu, M.D., from the University of Texas Southweste

Factors contributing to disparities in cancer death include race/ethnicity, socioeconomic status, geographic location, and age, according to a study published online Nov. 14 in CA: A Cancer Journal for Clinicians.Farhad Islami, M.D., Ph.D., from the American Cancer Society in Atlanta, and colleagues updated data on racial, ethnic, so

Type 2 diabetes is associated with an increased risk for colorectal cancer (CRC), with increased associations for those without colonoscopy screening and with smoking history, according to a study published online Nov. 14 in JAMA Network Open.Thomas Lawler, Ph.D., from the University of Wisconsin Carbone Cancer Center in Madison, and

The annual meeting of the American College of Gastroenterology was held from Oct. 20 to 25 in Vancouver, British Columbia, Canada, and attracted participants from around the world, including gastroenterology and digestive disease specialists and other health care professionals. The conference featured presentations focusing on clinical updates in gastr

Individuals in the upper range of fecal immunochemical test (FIT)-negative screening have an increased risk for advanced neoplasia (AN), according to a research letter published online Nov. 7 in the Annals of Internal Medicine.Tobias Niedermaier, Ph.D., from the German Cancer Research Center in Heidelberg, and colleagues provided a dose

Risk-adapted starting ages of screening vary by sex and polygenic risk score (PRS) among individuals at average risk for colorectal cancer (CRC), according to a study published online Oct. 25 in JAMA Network Open.Xuechen Chen, Ph.D., from the German Cancer Research Center in Heidelberg, and colleagues illustrated derivation of risk-adju